国产四虎,少妇厨房愉情理伦片bd在线观看,超碰95

EU Compromises! Trump: No One Knows Tariffs Better Than Me Trump The EU and US signed a controversial trade deal imposing 15% tariffs on EU exports and $750B in energy purchases from the US. Critics call it a one-sided surrender with major economic and political consequences for Europe.
Senate GOP Eyes Medicare Cuts in Push for Budget Bill Approval Trump Senate Republicans consider Medicare cuts targeting waste and fraud to advance a major budget bill passed by the House. The legislation includes Medicaid work requirements and faces strong opposition from healthcare groups.
Proposed NIH Cancer Research Cuts Spark Industry Concern ASCO The Trump administration’s proposed budget cuts to NIH and NCI risk hindering cancer research progress, prompting strong opposition from ASCO and ACS CAN over potential impacts on patient outcomes and innovation.
Trump's Pharma Tariffs & Pricing Reforms: S&P Warns of Generic Sector Risks Trump S&P Global reports that major pharma companies can withstand Trump’s proposed drug tariffs and MFN pricing, but warns that generic manufacturers may face serious risks from cost pressures and supply chain disruptions.
Federal Court Blocks HHS Reorganization Plan HHS A federal judge has blocked the Trump administration's plan to reorganize the Department of Health and Human Services, citing lack of congressional approval. The ruling halts mass layoffs and major program cuts affecting thousands of federal workers.
Trump Tax Bill Exempts Orphan Drugs, Targets PBMs White House The House narrowly passes Trump's "One Big Beautiful Bill Act," altering drug pricing rules and targeting PBMs, while the White House unveils the MAHA report to address childhood health and pharma influence.
Will Trump's Global Lowest Price Policy Work? Trump Trump's executive order to reduce U.S. drug prices by 30-80% has sparked debates and industry concerns. The policy aims to cut costs, but its feasibility and impact on global markets remain uncertain.
Trump Signs Executive Order to Accelerate Domestic Drug Manufacturing FDA On May 5, Trump signed an executive order to simplify regulations and accelerate domestic pharmaceutical manufacturing, aiming to reduce U.S. dependence on foreign drug production.
The Cost of Attacking the Pharmaceutical Industry Trump Trump's policies during his second term have rocked the U.S. scientific community, slashing NIH funding, threatening pharmaceutical innovation, and reshaping the global research landscape amid rising concerns about America's future in science.

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

永久免费毛片_亚洲成人看片_亚洲春色另类_亚洲综合免费视频_最新高清无码专区_午夜影院a